Creating vaccines for influenza and other infectious diseases
Official title: Task 02: Manufacture of Influenza for Human Challenge Clinical Trials
Funded at International AIDS Vaccine Initiative · NIH-9952278 · Data updated 2026-11-12
This study is all about creating new vaccines to help protect people from the flu and other infections, so patients can look forward to better options for staying healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | International AIDS Vaccine Initiative NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | May 15, 2018 |
| Project end | May 14, 2028 |
| Funding year | 2019 |
| Award (this year) | $1,217,730 |
| NIH project number | 272201800010I-P00001-27200002-1 |
| Project ID | NIH-9952278 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit include individuals at risk for influenza or those who may require vaccination against infectious diseases.
✕Less likely to help
Patients who are not at risk for influenza or other infectious diseases may not receive direct benefits from this research.
What this research studies
This research focuses on the development and manufacturing of vaccines for influenza and other infectious diseases. It involves planning, optimizing, and producing vaccine candidates in compliance with regulatory standards for clinical trials. Patients may benefit from the introduction of new vaccines that could provide better protection against flu and other infectious diseases. The project includes comprehensive support for regulatory submissions to ensure safety and efficacy.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective vaccines against influenza and other infectious diseases.
How similar studies have gone: Other research in vaccine development has shown success in creating effective vaccines for various infectious diseases, indicating a promising approach.
Where this research is happening
-
International AIDS Vaccine Initiative
New York, United States Active
Researchers
- Principal investigator: Hassell, Thomas — International AIDS Vaccine Initiative
- Study coordinator: Hassell, Thomas
Related research
Other NIH-funded projects on the same topics.
-
Creating vaccines for human trials against influenza and other infectious diseases
This study is working on creating new vaccines to help protect people from flu and other infectious diseases, including those that could be used in harmful situations, so that everyone can have safer and more effective options to stay healthy.
-
Understanding flu and COVID-19 vaccine responses in people and in the lab
Researchers at Stanford explore how flu and COVID-19 vaccines work in people and in lab tests to improve protection for adults.
-
Surveillance and preparedness for flu and other respiratory pathogens in Kenya
A US-based research grant aims to improve how Kenya detects and prepares for influenza and other respiratory diseases to protect people there and global health.
-
Enhanced Seasonal Influenza Vaccine Targeting Shared and Variable Viral Antigens
A new DNA-based influenza vaccine approach aims to provide both precise protection against circulating strains and broader defense against unexpected strains.
-
How the immune system responds to flu shots and flu infection
This project looks at how adults' immune systems react after flu shots or when they catch the flu to find why some people get better protection than others.
-
Influenza and SARS-CoV-2 in pregnancy in India
A study following pregnant women in India to track how flu and COVID viruses affect mothers and newborns.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.